As scientists learn more about COVID-19, it has become clear that the virus impacts people in different ways and that symptoms can range in severity.
It is well known that following a healthy lifestyle—not smoking, avoiding excess weight and getting regular exercise—can reduce the risk of heart disease. But what about people who have inherited gene variants known to increase risk?
A study led by Massachusetts General Hospital investigators has found that, even among those at high genetic risk, following a healthy lifestyle can cut in half the probability of a heart attack or similar event.
Their report is receiving early online publication in the New England Journal of Medicine to coincide with a presentation at the American Heart Association (AHA) Scientific Sessions.
“The basic message of our study is that DNA is not destiny,” says Sekar Kathiresan, MD, director of the Center for Human Genetic Research at Mass General, senior author of the NEJM report. “Many individuals—both physicians and members of the general public—have looked on genetic risk as unavoidable, but for heart attack that does not appear to be the case.”
In order to investigate whether a healthy lifestyle can mitigate genetic risk, the multi-institutional research team analyzed genetic and clinical data from more than 55,000 participants in four large-scale studies.
Three of these—the Atherosclerosis Risk in Communities Study, the Women’s Genome Health Study, and the Malmö Diet and Cancer Study—are prospective studies that have followed participants for up to 20 years. The fourth, the BioImage Study, assessed a variety of risk factors, including the presence of atherosclerotic plaques in the coronary arteries when participants joined the study.
Sekar Kathiresan, MD
“Some people may feel they cannot escape a genetically determined risk for heart attack, but our findings indicate that following a healthy lifestyle can powerfully reduce genetic risk.”
Director, Center for Human Genetic Research
Each participant in the current analysis was assigned a genetic risk score, based on whether they carried any of 50 gene variants that previous studies associated with elevated heart attack risk.
Based on data gathered when participants entered each study, the investigators used four AHA-defined lifestyle factors – no current smoking; lack of obesity, defined as a body mass index less than 30; physical exercise at least once a week, and a healthy dietary pattern—to determine a lifestyle score, whether participants had a favorable (three or four healthy factors), intermediate (two factors) or unfavorable (one or no healthy factors) lifestyle.
For participants in the prospective studies, the research team investigated how each individual’s genetic risk score and lifestyle factors related to the incidence of heart attack, the need for procedures designed to open blocked coronary arteries, or sudden cardiac death. Among participants in the BioImage study, genetic and lifestyle factors were compared to the extent of atherosclerotic disease in the coronary arteries at baseline.
Genetic Risk the Most Powerful Contributor
Across all three prospective studies, a higher genetic risk score significantly increased the incidence of coronary events—as much as 90 percent in those at highest risk. While known risk factors such as a family history and elevated LDL cholesterol were also associated with an elevated genetic risk score, genetic risk was the most powerful contributor to cardiac risk.
Similarly, each healthy lifestyle factor reduced risk, and the unfavorable lifestyle group also had higher levels of hypertension, diabetes and other known risk factors upon entering the studies.
Within each genetic risk category, the presence of lifestyle factors significantly altered the risk of coronary events to such an extent that following a favorable lifestyle could reduce the incidence of coronary events by 50 percent in those with the highest genetic risk scores. Among participants in the BioImage study, both genetic and lifestyle factors were independently associated with levels of calcium-containing plaque in the coronary arteries, and healthy lifestyle factors were associated with less extensive plaque within each genetic risk group.
“Some people may feel they cannot escape a genetically determined risk for heart attack, but our findings indicate that following a healthy lifestyle can powerfully reduce genetic risk,” says Kathiresan, who is director of the Cardiovascular Disease Initiative at the Broad Institute of MIT and Harvard and an associate professor of Medicine at Harvard Medical School. “Now we need to investigate whether specific lifestyle factors have stronger impacts and conduct studies in more diverse populations, since most of the participants in these studies are white.”
The lead authors of the NEJM paper are Amit Khera, MD, Mass General Cardiology and Center for Human Genetic Research (CHGR), and Connor Emdin, DPhil, Broad Institute. Additional co-authors are Pradeep Natarajan, MD, Mass General Cardiology and CHGR; Nancy Cook, PhD, Daniel Chasman, PhD, and Paul Ridker, MD, Brigham and Women’s Hospital; Alexander Bick, MD, PhD, Broad Institute; Isabel Drake, PhD, Olle Melander, MD, PhD, and Marju Orho-Melander, PhD, Lund University, Malmö, Sweden; Usman Baber, MD, Roxana Mehran, MD, and Valentin Fuster, MD, PhD, Mount Sinai Medical Center; Daniel Rader, MD, University of Pennsylvania, and Eric Boerwinkle, PhD, University of Texas Health Science Center School of Public Health. Support for the study includes an American College of Cardiology – Merck Research Fellowship and a John S. Ladue Memorial Fellowship from Harvard Medical School.
About Mass General
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $800 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The Mass General topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals, earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2016 the Mass General was once again named to the Honor Roll in the U.S. News & World Report list of "America's Best Hospitals."
- Jun | 25 | 2020
A third of Americans show signs of clinical depression and an anxiety. These and other mental conditions are becoming amplified during the recent pandemic, while COVID-19 patients and their families are also at high risk to develop depression and anxiety.
- Jun | 23 | 2020
As the initial surge of the COVID-19 pandemic subsides, Massachusetts General Hospital leaders are discussing the transition to strategies for recovery and wellness.
- Jun | 17 | 2020
El Dr. Amir Mohareb describe las medidas que puede tomar para reducir el riesgo de contraer el coronavirus al regresar al trabajo.
- Jun | 17 | 2020
Amir Mohareb, MD, of the Infectious Disease Division at Massachusetts General Hospital, outlines steps you can take to reduce your risk for the coronavirus when going back to work.
- Clinician Resource
- Jun | 12 | 2020
The Home Base Program at Mass General Hospital is dedicated to providing mental health care and support for Veterans of all eras, Active Duty Service Members, National Guard and Reserve members, and their families – all at no cost.